Attendee search 

Gray Box Biology LLC is a Scientific Consultants business in 11354 Flushing, New York 

Evercore (NYSE:EVR) is a leading independent investment banking advisory firm. Evercore’s Investment Banking business advises its clients on mergers, acquisitions, divestitures, restructurings, financings, public offerings, private placements and other strategic transactions and also provides institutional investors with high quality equity research, sales and trading execution that is free of the conflicts created by proprietary activities. Evercore’s Investment Management business comprises wealth management, institutional asset management and private equity investing. Evercore serves a diverse set of clients around the world from 28 offices in North America, Europe, South America and Asia. More information about Evercore can be found on the Company’s website at www.evercore.com. 


Investment Banking 

- Corporate Advisory 
- Restructuring Advisory 
- Evercore ISI 
- Private Funds Group 
- Private Capital Advisory 


Investment Management 

- Institutional Asset Management 
• Atalanta Sosnoff Capital 
• Evercore Trust Company 
• Evercore Casa de Bolsa 

- Wealth Management 
• Evercore Wealth Management 

- Private Equity 
• Evercore Mexico Capital Partners 
• Trilantic Capital Partners

HealthiosXchange is the premier online capital market dedicated exclusively to the global healthcare industry. Employing “Crowdfunding” as the cornerstone of a new paradigm in healthcare investing, the H/X offers direct access from "seed" to "exit" to the most promising healthcare companies on a “No Fee No Carry” basis. 

Healthios, the founder of HealthiosXchange, is a boutique investment bank dedicated exclusively to the global healthcare industry: 

- The most compelling growth companies 
- The most dynamic industry sectors 
- The most sophisticated institutional investors 
- The most active strategic buyers and partners 

Healthios seeks to be the premier investment bank serving the global healthcare industry by combining the experience of (52) transactions in 17 countries with unique access to capital, resources and ideas that are the foundation of superior value.

Financing, Partnering, Capital Markets, M&A

We are developing the first GI platform based on uroguanylin – a naturally occurring human peptide that plays a key role in regulating normal digestive activity

Defined Health advises senior management at Life Sciences clients on the value of compounds  and technology platforms in development, from pre-IND to indication prioritization and sequencing,, repurposing, reformulation, and life cycle management. Our scientifically trained consultants leverage the firm's 30 years of experience with evaluations that are grounded in the science, and informed by an unparalleled understanding of current and evolving clinical practices, development and regulatory issues, competitive commercial dynamics and pricing, reimbursement and market access practices. 

In addition to our core Opportunity Assessment business, we have a large Search & Evaluation practice, wherein we identify and assess relevant opportunities for therapeutic area expansion, as well as a Strategy practice that addresses broader corporate development initiatives -- therapeutic and disease area and market entry strategies.

Our clients include 13 of the top 20 pharmacos, 6 of the top 10 large cap biotechs, and scores of specialty pharma and pre-commercial biotech companies, as well as several royalty investors and two of the top private equity firms.  We are proud to have an 80% repeat and referral client base.

Find out more about Defined Health and view our recent presentations on topical and therapeutic area specific subjects at www.definedhealth.com.

Dr. Jeffrey Lombardo is the executive patient safety officer for UB’s patient safety organization Empire State Patient Safety Assurance Network. In this role he facilitates organization participation, logistics and implementation with participating sites as well as reviewing data and presenting reports on findings. Working with CCS Oncology he is tracking patient outcomes and advising physicians on best practices for cancer patients making full use of his specialty pharmacy certification in oncology. Dr. Lombardo is also a member of the SUNY Global Health Institute where he will be bringing his patient safety and oncology expertise to partner schools like the University of the West Indies for various collaborations. In Jamaica he will be partnering with Citivia Medical for studies on medical marijuana and pursuing new initiatives for the University at Buffalo’s medication management research network. (MMRN)

Dr. Lombardo received his Doctorate in Pharmacy from the University at Buffalo where he currently holds a Research Assistant Professor Title. He has completed research and co-authored several articles on topics involving chemotherapy in the field of solid tumors. Dr. Lombardo has worked in various cancer pharmacies throughout Western New York as well a national oncology specialty pharmacy. These roles provided Dr. Lombardo with expertise in contracting with managed care plans and companies in the pharmaceutical industry. In addition to these accomplishments Dr. Lombardo has exhibited and presented his work at the American Society of Clinical Oncology, American Society of Health System Pharmacists and Value Based Cancer Care Symposiums.

La Petite Noiseuse Productions merges Neuroscience and Art to create the next generation of innovative content development and products within information visualization, artificial intelligence and design.